Related Experiment Video
Updated: Aug 7, 2026
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Surgical myocardial revascularization
J W Jones1, S E Schmidt, B W Richman
1Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Insights
Surgical myocardial revascularization evolved from microcirculation to macrovascular approaches like coronary bypass. Newer therapies, including laser channels, offer hope for patients with advanced coronary artery disease.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Myocardial Revascularization
Background:
- Historically, myocardial revascularization focused on microcirculation to improve blood flow to the myocardium.
- Angiography revealed macrovascular obstructions, shifting focus to direct intervention on coronary arteries.
Observation:
- Coronary artery bypass grafting dominated for three decades, but surgical conduits have limited longevity and availability.
- Alternative conduits (biologic, prosthetic) have not matched the clinical success of the internal thoracic artery (ITA).
- Increasing patient longevity leads to advanced disease exhausting conventional therapies.
Findings:
- Newer therapies, such as laser channel creation, are being explored for untreatable cases, revisiting microcirculation.
- These innovative procedures have benefited numerous patients, demonstrating progress in surgical techniques.
Implications:
- The evolution of surgical techniques reflects a continuous effort to address coronary artery blockages effectively.
- Ongoing innovation is crucial for developing sustainable and effective treatments for myocardial revascularization.
Abstract:
In conclusion, surgical myocardial revascularization has utilized diverse methods to increase blood flow to the starving myocardium. These methods initially used the microcirculation as the portal to reach myocytes until angiography showed that the obstructions were macrovascular. This resulted in a 30-year era of direct attack on the coronary blockages by coronary bypass. Surgical conduits unfortunately have longevity considerably less than that of native arteries and are limited in number. Alternative conduits, both biologic and prosthetic, have not yet proved to have the same clinical results as the ITA. More patients are living long enough to have the extensiveness of their disease exhaust conventional therapies. Newer therapy, restricted thus far to untreatables, revisits the microcirculation by making laser channels. These many innovative procedures have benefited hundreds of thousands of patients. They emerged from the probity and innovation of many individual surgeons.
More Related Videos
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management